Related Experiment Video

Updated: Jul 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Testosterone replacement therapy and prostate cancer: a word of caution

Timothy C Brand1, Edith Canby-Hagino, Ian M Thompson

  • 1Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. brandt2@uthscsa.edu

Current Urology Reports
|April 27, 2007
PubMed

Insights

Testosterone replacement therapy is increasingly prescribed for aging men experiencing hypogonadism symptoms. More research is needed on its efficacy and safety, especially concerning prostate cancer risk.

Area of Science:

  • Endocrinology
  • Men's Health
  • Geriatrics

Background:

  • Testosterone levels naturally decline with age.
  • Aging men may experience hypogonadism symptoms like erectile dysfunction, low libido, sarcopenia, and depression.
  • Prescription rates for testosterone are rising.

Purpose of the Study:

  • To review concerns and recommendations for testosterone replacement therapy (TRT) in aging men.
  • To highlight the limited data on TRT efficacy and safety.
  • To address the potential impact of TRT on prostate cancer risk.

Main Methods:

  • Literature review of existing studies on testosterone levels, hypogonadism, and TRT.
  • Analysis of current data regarding TRT's effects on men's health and prostate cancer.
  • Synthesis of concerns and formulation of clinical recommendations.

Main Results:

  • Significant data gaps exist regarding the efficacy and safety of TRT.
  • Testosterone levels influence prostate cancer risk and progression.
  • Prospective studies on TRT and prostate cancer risk are lacking.

Conclusions:

  • TRT use in aging men requires careful consideration due to limited evidence.
  • Further prospective research is essential to evaluate TRT's long-term safety and efficacy, particularly its relationship with prostate cancer.
  • Clinical guidelines should address the current uncertainties surrounding TRT for aging men.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...